Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Tobin

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Molecular Pharmacology|September 2, 2011
Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL)Elisa Alvarez-Curto, Rudi Prihandoko, Christofer S Tautermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2021
Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion diseaseJulie-Myrtille Bourgognon, Jereme G Spiers, Sue W Robinson, et al.
RSC Medicinal Chemistry|June 16, 2025
Lysine targeting covalent inhibitors of malarial kinase <i>Pf</i>CLK3Skye B Brettell, Gillian Cann, Abbey Begen, et al.
Scientific Reports|February 14, 2019
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84Sarah J Mancini, Zobaer Al Mahmud, Laura Jenkins, et al.
Frontiers in Pharmacology|February 15, 2021
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and BiasEmma T van der Westhuizen, K H Christopher Choy, Celine Valant, et al.
Molecular Pharmacology|August 28, 2013
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismBrian D Hudson, Bharat Shimpukade, Amanda E Mackenzie, et al.
The Journal of Biological Chemistry|September 3, 2023
G protein-receptor kinases 5/6 are the key regulators of G protein-coupled receptor 35-arrestin interactionsAmlan Ganguly, Tezz Quon, Laura Jenkins, et al.
ACS Chemical Neuroscience|November 16, 2020
Restoring Agonist Function at a Chemogenetically Modified M<sub>1</sub> Muscarinic Acetylcholine ReceptorElham Khajehali, Sophie Bradley, Emma T van der Westhuizen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 3, 2019
Receptor selectivity between the G proteins Gα<sub>12</sub> and Gα<sub>13</sub> is defined by a single leucine-to-isoleucine variationAmanda E Mackenzie, Tezz Quon, Li-Chiung Lin, et al.
Scientific Reports|March 4, 2016
Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestinsMonica Bouzo-Lorenzo, Icía Santo-Zas, Maria Lodeiro, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Molecular Pharmacology|September 2, 2011
Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL)Elisa Alvarez-Curto, Rudi Prihandoko, Christofer S Tautermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2021
Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion diseaseJulie-Myrtille Bourgognon, Jereme G Spiers, Sue W Robinson, et al.
RSC Medicinal Chemistry|June 16, 2025
Lysine targeting covalent inhibitors of malarial kinase <i>Pf</i>CLK3Skye B Brettell, Gillian Cann, Abbey Begen, et al.
Scientific Reports|February 14, 2019
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84Sarah J Mancini, Zobaer Al Mahmud, Laura Jenkins, et al.
Frontiers in Pharmacology|February 15, 2021
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and BiasEmma T van der Westhuizen, K H Christopher Choy, Celine Valant, et al.
Molecular Pharmacology|August 28, 2013
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismBrian D Hudson, Bharat Shimpukade, Amanda E Mackenzie, et al.
The Journal of Biological Chemistry|September 3, 2023
G protein-receptor kinases 5/6 are the key regulators of G protein-coupled receptor 35-arrestin interactionsAmlan Ganguly, Tezz Quon, Laura Jenkins, et al.
ACS Chemical Neuroscience|November 16, 2020
Restoring Agonist Function at a Chemogenetically Modified M<sub>1</sub> Muscarinic Acetylcholine ReceptorElham Khajehali, Sophie Bradley, Emma T van der Westhuizen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 3, 2019
Receptor selectivity between the G proteins Gα<sub>12</sub> and Gα<sub>13</sub> is defined by a single leucine-to-isoleucine variationAmanda E Mackenzie, Tezz Quon, Li-Chiung Lin, et al.
Scientific Reports|March 4, 2016
Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestinsMonica Bouzo-Lorenzo, Icía Santo-Zas, Maria Lodeiro, et al.
Pageof 13